Insider Stock Trading History of Ruegg Curtis


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ruegg Curtis since year 2005. The trader's CIK number is 1597578. At the time of this reporting, Ruegg Curtis is the EVP, Technical Operations of Revance Therapeutics, Inc. . (stock ticker symbol RVNC). See this page for all insider trading activities at Revance Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Ruegg Curtis since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-06-13 RVNC Revance Therapeutics, Inc. Option Ex 1,000 8.70 8,700
2016-06-13 RVNC Revance Therapeutics, Inc. Sale 1,000 18.25 18,250
2016-05-09 RVNC Revance Therapeutics, Inc. Sale 1,000 16.18 16,180
2016-05-09 RVNC Revance Therapeutics, Inc. Option Ex 1,000 8.70 8,700
2016-04-11 RVNC Revance Therapeutics, Inc. Option Ex 1,000 8.70 8,700
2016-04-11 RVNC Revance Therapeutics, Inc. Sale 1,000 19.11 19,110
2016-03-07 RVNC Revance Therapeutics, Inc. Sale 1,000 20.43 20,430
2016-03-07 RVNC Revance Therapeutics, Inc. Option Ex 1,000 8.70 8,700
2016-02-08 RVNC Revance Therapeutics, Inc. Option Ex 1,000 8.70 8,700
2016-02-08 RVNC Revance Therapeutics, Inc. Sale 1,000 18.14 18,140
2016-01-06 RVNC Revance Therapeutics, Inc. Option Ex 2,000 8.70 17,400
2016-01-06 RVNC Revance Therapeutics, Inc. Sale 2,000 33.06 66,120
2015-08-17 RVNC Revance Therapeutics, Inc. Sale 3,000 30.49 91,482
2015-08-17 RVNC Revance Therapeutics, Inc. Option Ex 3,000 8.70 26,099
2015-07-17 RVNC Revance Therapeutics, Inc. Option Ex 3,000 7.65 22,950
2015-07-17 RVNC Revance Therapeutics, Inc. Sale 3,000 31.03 93,090
2015-06-17 RVNC Revance Therapeutics, Inc. Option Ex 3,000 6.60 19,800
2015-06-17 RVNC Revance Therapeutics, Inc. Sale 3,000 33.53 100,593
2015-06-03 RVNC Revance Therapeutics, Inc. Option Ex 500 6.60 3,300
2015-06-03 RVNC Revance Therapeutics, Inc. Sale 500 30.00 15,000
2015-05-18 RVNC Revance Therapeutics, Inc. Option Ex 2,500 6.60 16,500
2015-05-18 RVNC Revance Therapeutics, Inc. Sale 2,500 26.69 66,735
2015-05-15 RVNC Revance Therapeutics, Inc. Option Ex 500 6.60 3,300
2015-05-15 RVNC Revance Therapeutics, Inc. Sale 500 25.00 12,500
2015-04-17 RVNC Revance Therapeutics, Inc. Option Ex 2,000 6.60 13,200
2015-04-17 RVNC Revance Therapeutics, Inc. Sale 2,000 22.23 44,466
2015-03-19 RVNC Revance Therapeutics, Inc. Option Ex 500 6.60 3,300
2015-03-19 RVNC Revance Therapeutics, Inc. Sale 500 20.00 10,000
2015-03-17 RVNC Revance Therapeutics, Inc. Option Ex 1,500 6.60 9,900
2015-03-17 RVNC Revance Therapeutics, Inc. Sale 1,500 18.61 27,915
2015-03-09 RVNC Revance Therapeutics, Inc. Option Ex 500 6.60 3,300
2015-03-09 RVNC Revance Therapeutics, Inc. Sale 500 18.00 9,000
2015-02-17 RVNC Revance Therapeutics, Inc. Option Ex 1,000 4.58 4,575
2015-02-17 RVNC Revance Therapeutics, Inc. Sale 1,000 16.80 16,800
2015-01-20 RVNC Revance Therapeutics, Inc. Option Ex 1,000 2.55 2,550
2015-01-20 RVNC Revance Therapeutics, Inc. Sale 1,000 17.25 17,250
2015-01-09 RVNC Revance Therapeutics, Inc. Sale 500 18.00 9,000
2015-01-09 RVNC Revance Therapeutics, Inc. Option Ex 500 2.55 1,275
2014-12-17 RVNC Revance Therapeutics, Inc. Option Ex 1,000 2.55 2,550
2014-12-17 RVNC Revance Therapeutics, Inc. Sale 1,000 16.45 16,450
2014-12-09 RVNC Revance Therapeutics, Inc. Option Ex 500 2.55 1,275
2014-12-09 RVNC Revance Therapeutics, Inc. Sale 500 18.00 9,000
2014-11-18 RVNC Revance Therapeutics, Inc. Sale 1,000 16.00 16,000
2014-11-18 RVNC Revance Therapeutics, Inc. Option Ex 1,000 2.55 2,550
2014-10-28 RVNC Revance Therapeutics, Inc. Option Ex 500 2.55 1,275
2014-10-28 RVNC Revance Therapeutics, Inc. Sale 500 20.00 10,000
2014-10-17 RVNC Revance Therapeutics, Inc. Option Ex 1,500 2.55 3,824
2014-10-17 RVNC Revance Therapeutics, Inc. Sale 1,500 18.54 27,814
2014-09-17 RVNC Revance Therapeutics, Inc. Option Ex 1,162 2.55 2,963
2014-09-17 RVNC Revance Therapeutics, Inc. Sale 2,000 20.54 41,074

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ruegg Curtis (EVP, Technical Operations of Revance Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.